Septerna (SEPN) Current Taxes (2023 - 2024)
Septerna's quarterly Current Taxes came in at $200000.0 in Q3 2024, little changed quarter-over-quarter from $200000.0 in Q4 2023.
Septerna has reported Current Taxes for 2 years, with the latest figure at $200000.0 in Q3 2024.
- For the quarter ending Q3 2024, Current Taxes changed N/A year-over-year to $200000.0; the trailing twelve-month figure through Sep 2024 stood at $200000.0 (changed N/A YoY), and the FY2023 full-year result was $200000.0, changed N/A from the prior year.
- Current Taxes for Q3 2024 stood at $200000.0, roughly flat from $200000.0 in the prior quarter.
- The five-year high for Current Taxes was $200000.0 in Q4 2023, with the low at $200000.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 10,460.56 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 19.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |